Skip to content

Clinical trials

Completed Hyperlipoproteinemia Type II trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Phase: Not applicable Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20141
20151
20162
20181
20192
20201
20212
20224
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Laval University3
University of Pennsylvania3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Boston Children's Hospital1
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland1
Central Park Medical College1
Fresenius Medical Care Deutschland GmbH1
Geisinger Clinic1
Hospital do Coracao1
Instituto Aragones de Ciencias de la Salud1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II21
Hypercholesterolemia4
Cardiovascular Diseases2
Obesity2
Overweight2
Acute Coronary Syndrome1
Atherosclerosis1
Dyslipidemias1
Glucose Intolerance1
Gyrate Atrophy1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.